Cargando…
Sphingolipid abnormalities in encephalomyeloradiculoneuropathy (EMRN) are associated with an anti‐neutral glycolipid antibody
Accumulating evidence suggests that various sphingolipids and glycosphingolipids can act as mediators for inflammation or signaling molecules in the nervous system. In this article, we explore the molecular basis of a new neuroinflammatory disorder called encephalomyeloradiculoneuropathy (EMRN), whi...
Autores principales: | Mutoh, Tatsuro, Ueda, Akihiro, Niimi, Yoshiki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476566/ https://www.ncbi.nlm.nih.gov/pubmed/36807737 http://dx.doi.org/10.1002/2211-5463.13578 |
Ejemplares similares
-
The first pediatric anti-lactosylceramide antibody-positive encephalomyeloradiculoneuropathy
por: Sasaki, Akiko, et al.
Publicado: (2022) -
A Patient With Encephalomyeloradiculoneuropathy Exhibiting a Relapsing–Remitting Clinical Course: Correlation of Serum and Cerebrospinal Fluid Anti-Neutral Glycosphingolipids Antibodies With Clinical Relapse
por: Nanaura, Hitoki, et al.
Publicado: (2018) -
Fatigue evaluated using the 16-item Parkinson Fatigue Scale
(PFS-16) predicts Parkinson’s disease prognosis
por: Niimi, Yoshiki, et al.
Publicado: (2019) -
Neutralization of meningococcal endotoxin by antibody to core glycolipid
Publicado: (1978) -
Encephalomyeloradiculoneuropathy Revealing a Rare Case of Intravascular Large B-Cell Lymphoma
por: Aasfara, Jehanne, et al.
Publicado: (2021)